Is Long-Term Melatonin Safe for Angelman Syndrome?
At a Glance
Long-term melatonin use is generally safe and well-tolerated for managing sleep disturbances in Angelman syndrome. It is most effective when combined with targeted behavioral strategies and FDA-approved physical safety measures, all under the guidance of a physician.
In this answer
3 sections
Sleep disturbances are incredibly common in Angelman syndrome, often characterized by trouble falling asleep, frequent nighttime awakenings, and very short overall sleep duration [1]. If your child is struggling to sleep, it is entirely understandable to consider daily melatonin use. Current evidence suggests that long-term melatonin use is generally safe and well-tolerated for managing sleep in children with neurodevelopmental conditions, including Angelman syndrome, though it works best when combined with behavioral strategies and proper safety measures [2][3]. Because many children with Angelman syndrome take complex anti-seizure regimens, you must clear any new supplement, including over-the-counter melatonin, with your neurologist or pediatrician to ensure it does not interact with existing medications [4].
How Melatonin Works in Angelman Syndrome
Melatonin is a hormone naturally produced by the body to help regulate the sleep-wake cycle (the circadian rhythm). Many children with neurodevelopmental disorders benefit from melatonin supplementation to reduce the time it takes to fall asleep and improve sleep quality [5][6]. It is typically given 30 to 60 minutes before the desired bedtime [7].
While standard, immediate-release melatonin can be very effective at helping a child fall asleep, it is often less effective at keeping them asleep throughout the night [1]. If your child frequently wakes up in the middle of the night, ask your doctor if an extended-release (or prolonged-release) melatonin formulation might be a better option to help them stay asleep [8]. Management of sleep in Angelman syndrome is largely based on clinical expertise and typically requires a multi-layered approach [4].
Safety and Long-Term Use
Exogenous (supplemental) melatonin is generally considered well-tolerated in pediatric populations with no obvious short- or long-term adverse effects reported in most clinical studies [2][9]. Moderate doses (typically under 5-6 mg daily) are commonly reported as effective and safe by parents [10].
Some parents worry about whether long-term melatonin use might affect puberty. In animal models, high doses of melatonin have been shown to influence the timing of puberty by interacting with the hormones that control development [11][12]. However, there are currently no robust, long-term human studies proving that chronic melatonin use causes clinically significant delays or early onset of puberty in children with neurodevelopmental disorders [13][14]. Because long-term data is still limited, it is best to use the lowest effective dose under the guidance of your care team [13].
A Complete Approach: Medication, Behavior, and Environment
Because melatonin alone is rarely a cure-all for sleep issues in Angelman syndrome, experts recommend combining it with non-pharmacological approaches [3][15].
Behavioral Interventions
Behavioral sleep training and good sleep hygiene are essential. For children with Angelman syndrome, standard advice like “no screens before bed” is often not enough. Studies show that targeted behavioral techniques combined with parent education can have a lasting impact [15]. Concrete strategies include:
- Faded bedtime: Temporarily moving bedtime later to match when the child naturally falls asleep, then gradually shifting it earlier by 15-minute increments.
- Low-stimulation environments: Ensuring the bedroom is strictly used for sleep, keeping it dark, quiet, and free of stimulating toys or activities.
- Consistent calming routines: Establishing a very predictable, sensory-friendly wind-down routine every single night.
Anxiety and certain repetitive behaviors (like wall slapping or agitation) are also linked to poor sleep in this population, so addressing these daytime behaviors and finding ways to de-escalate anxiety may improve nighttime rest [16][17].
Physical Safety and Enclosed Beds
For children with Angelman syndrome who wake frequently and may wander or engage in unsafe behaviors at night, physical safety is a top priority. Canopy-enclosed beds (often called safety beds) can keep a child safe while they are awake in the middle of the night, potentially reducing the need for heavy, behavior-altering medications [18].
Critical Safety Warning: You must only use properly prescribed, FDA-approved medical safety beds. Strictly avoid DIY solutions or unapproved aftermarket sleep tents. Improperly designed enclosures carry a severe, life-threatening risk of entrapment, strangulation, and suffocation. Always ensure any bed is the least restrictive option for the child’s safety and well-being [18]. Because these approved beds are very expensive, you can often work with your doctor to provide a “Letter of Medical Necessity” to have them covered by insurance or Medicaid waivers.
Checking Iron Levels and Other Causes
Physical discomfort or restlessness can disrupt sleep. Low iron levels, specifically low ferritin (a protein that stores iron), can exacerbate sleep disturbances in children with Angelman syndrome, and supplementing iron when levels are low can offer modest improvements [19]. Additionally, frequent nighttime awakenings should always be evaluated by a doctor to rule out other underlying medical causes common in Angelman syndrome, such as sleep apnea or nocturnal seizures [4].
Common questions in this guide
Is long-term melatonin use safe for children with Angelman syndrome?
What type of melatonin is best if my child wakes up during the night?
Will melatonin interfere with my child's anti-seizure medications?
What is a medical safety bed and when is it used?
Are there other medical reasons my child might not be sleeping well?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What is the recommended starting dose of melatonin for my child, and should we consider an extended-release formulation to help them stay asleep?
- 2.How can we make sure melatonin won't interact with any of my child's current anti-seizure medications?
- 3.Should we check my child's ferritin levels or evaluate for sleep apnea or nocturnal seizures as contributing factors to their sleep issues?
- 4.What are our options if melatonin helps my child fall asleep but they still wake up frequently in the middle of the night?
- 5.Are there specialized behavioral sleep clinics or therapists you can refer us to who have experience with neurodevelopmental disorders?
- 6.If we want to consider an FDA-approved enclosed safety bed, how do we start that process and can you help with a letter of medical necessity?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (19)
- 1
Sleep in Angelman syndrome: A review of evidence.
Spruyt K, Braam W, Curfs LM
Sleep medicine reviews 2018; (37()):69-84 doi:10.1016/j.smrv.2017.01.002.
PMID: 28784434 - 2
A review of sleep disorders and melatonin.
Xie Z, Chen F, Li WA, et al.
Neurological research 2017; (39(6)):559-565 doi:10.1080/01616412.2017.1315864.
PMID: 28460563 - 3
Therapeutic approach to neurological manifestations of Angelman syndrome.
Ascoli M, Elia M, Gasparini S, et al.
Expert review of clinical pharmacology 2022; (15(7)):843-850 doi:10.1080/17512433.2022.2109463.
PMID: 35917229 - 4
Management of Sleep Disorders in Children With Neurodevelopmental Disorders: A Review.
Blackmer AB, Feinstein JA
Pharmacotherapy 2016; (36(1)):84-98 doi:10.1002/phar.1686.
PMID: 26799351 - 5
Role of Melatonin in the Management of Sleep and Circadian Disorders in the Context of Psychiatric Illness.
Moon E, Kim K, Partonen T, Linnaranta O
Current psychiatry reports 2022; (24(11)):623-634 doi:10.1007/s11920-022-01369-6.
PMID: 36227449 - 6
The use and misuse of exogenous melatonin in the treatment of sleep disorders.
Riha RL
Current opinion in pulmonary medicine 2018; (24(6)):543-548 doi:10.1097/MCP.0000000000000522.
PMID: 30148726 - 7
Clinical Practice Guideline for the Treatment of Intrinsic Circadian Rhythm Sleep-Wake Disorders: Advanced Sleep-Wake Phase Disorder (ASWPD), Delayed Sleep-Wake Phase Disorder (DSWPD), Non-24-Hour Sleep-Wake Rhythm Disorder (N24SWD), and Irregular Sleep-Wake Rhythm Disorder (ISWRD). An Update for 2015: An American Academy of Sleep Medicine Clinical Practice Guideline.
Auger RR, Burgess HJ, Emens JS, et al.
Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 2015; (11(10)):1199-236 doi:10.5664/jcsm.5100.
PMID: 26414986 - 8
Melatonin Interventions in Autism Spectrum Disorder: Sleep Regulation, Behavioral Outcomes, and Challenges Across the Lifespan.
Bjørklund G, Oleshchuk O, Ivankiv Y, et al.
Molecular neurobiology 2025; (62(8)):9710-9732 doi:10.1007/s12035-025-04809-5.
PMID: 40138120 - 9
Melatonin as an immunomodulator in children with Down syndrome.
Huggard D, Kelly L, Worrall A, et al.
Pediatric research 2022; (91(7)):1812-1820 doi:10.1038/s41390-021-01611-6.
PMID: 34400791 - 10
Chronic Administration of Melatonin: Physiological and Clinical Considerations.
Givler D, Givler A, Luther PM, et al.
Neurology international 2023; (15(1)):518-533 doi:10.3390/neurolint15010031.
PMID: 36976674 - 11
Exogenous Melatonin Regulates Puberty and the Hypothalamic GnRH-GnIH System in Female Mice.
Chen Z, Si L, Shu W, et al.
Brain sciences 2022; (12(11)) doi:10.3390/brainsci12111550.
PMID: 36421874 - 12
Effect of melatonin on the onset of puberty in male juvenile rats.
Venugopal SP
Anatomy & cell biology 2019; (52(3)):286-295 doi:10.5115/acb.18.122.
PMID: 31598358 - 13
Melatonin supplementation: new insights into health and disease.
Minari TP, Pisani LP
Sleep & breathing = Schlaf & Atmung 2025; (29(2)):169 doi:10.1007/s11325-025-03331-1.
PMID: 40278958 - 14
Could long-term administration of melatonin to prepubertal children affect timing of puberty? A clinician's perspective.
Boafo A, Greenham S, Alenezi S, et al.
Nature and science of sleep 2019; (11()):1-10 doi:10.2147/NSS.S181365.
PMID: 30774488 - 15
Sleep problems in children with Angelman Syndrome: The effect of a behavioral intervention program.
Bindels-de Heus KGCB, Hooven-Radstaake MT, Legerstee JS, et al.
Research in developmental disabilities 2023; (135()):104444 doi:10.1016/j.ridd.2023.104444.
PMID: 36753818 - 16
Factors associated with sleep disturbances in children and adolescents with Angelman Syndrome.
Leader G, Killeen C, Whelan S, et al.
Sleep medicine 2024; (117()):9-17 doi:10.1016/j.sleep.2024.02.038.
PMID: 38479041 - 17
Association between sleep disturbances and challenging behavior in children and adolescents with Angelman syndrome.
O'Donohoe DS, Whelan S, Mannion A, et al.
Sleep medicine 2024; (123()):1-6 doi:10.1016/j.sleep.2024.07.033.
PMID: 39222563 - 18
[Canopy-enclosed bed for dementia patients with behavioural problems].
Molleman PW, van Kesteren JB, Ubink-Bontekoe CJ, et al.
Nederlands tijdschrift voor geneeskunde 2015; (159()):A9617.
PMID: 26577384 - 19
Iron Deficiency and Its Role in Sleep Disruption in Patients With Angelman Syndrome.
Ryan CS, Edlund W, Mandrekar J, et al.
Journal of child neurology 2020; (35(14)):963-969 doi:10.1177/0883073820941755.
PMID: 32713229
This page provides information on sleep management for educational purposes only. Always consult your child's neurologist or pediatrician before starting melatonin or using specialized safety beds to ensure it is safe for their specific medical needs.
Get notified when new evidence is published on Angelman syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.